Premium
Rubella Antibody Titres, Rubella Vaccination, and the Obstetrician
Author(s) -
Giles P. F. H.,
MackayScollay E. M.,
Christiansen K.
Publication year - 1973
Publication title -
australian and new zealand journal of obstetrics and gynaecology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.734
H-Index - 65
eISSN - 1479-828X
pISSN - 0004-8666
DOI - 10.1111/j.1479-828x.1973.tb02283.x
Subject(s) - rubella , medicine , vaccination , rubella vaccine , rubella virus , immunology , pregnancy , rash , cord blood , antibody , measles , obstetrics , hemagglutination , virology , pediatrics , biology , genetics
Summary : The performance of a rubella haemagglutination‐inhibition antibody test at the first antenatal visit of 1,765 women was found to have several advantages; the 81% of patients found to be immune were reassured, the 19% at risk were identified, told what to do if they should be exposed to rubella or developed a rash, and were subsequently offered rubella vaccination in the puerperium. Rubella antibody titres of maternal and cord blood are compared and any significant differences are discussed. One case of rubella in pregnancy, and another of rubella vaccination just before conception, are presented. Of 20 mothers vaccinated in the puerperium, 5 reported side effects, and 2 did not develop antibodies. The place of tests on cord bloods for rubella haemagglutination‐inhibiting antibodies is discussed.